We are live on ! Find out more
KCM

Kornitzer Capital Management Portfolio holdings

AUM $4.79B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$4.94B
AUM Growth
+$275M
Cap. Flow
-$134M
Cap. Flow %
-2.72%
Top 10 Hldgs %
16.92%
Holding
527
New
22
Increased
110
Reduced
192
Closed
28

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$9.95M
2
OABI icon
OmniAb
OABI
+$9.24M
3
CLFD icon
Clearfield
CLFD
+$7.38M
4
MPWR icon
Monolithic Power Systems
MPWR
+$7.32M
5
SITM icon
SiTime
SITM
+$7.29M

Sector Composition

Rank Sector Weight
1 Technology 20.04%
2 Healthcare 18.33%
3 Energy 13.38%
4 Consumer Staples 11.65%
5 Industrials 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADM icon
51
Archer Daniels Midland
ADM
$38.8B
$22.4M 0.45%
241,253
-1,570
-0.6% -$145K
ICFI icon
52
ICF International
ICFI
$1.64B
$22.2M 0.45%
224,019
-21,181
-9% -$2.31M
TASK icon
53
TaskUs
TASK
$651M
$22M 0.45%
1,300,669
SPGI icon
54
S&P Global
SPGI
$121B
$21.8M 0.44%
64,974
-10,142
-14% -$3.34M
AZN icon
55
AstraZeneca
AZN
$251B
$21.7M 0.44%
160,223
-365
-0.2% -$45.8K
K
56
DELISTED
Kellanova
K
$21.5M 0.44%
321,935
-3,302
-1% -$224K
AME icon
57
Ametek
AME
$58B
$21.4M 0.43%
152,855
-57,426
-27% -$7.61M
AZTA icon
58
Azenta
AZTA
$1.54B
$20.7M 0.42%
355,885
+106,399
+43% +$5.44M
EVH icon
59
Evolent Health
EVH
$444M
$20.6M 0.42%
733,356
+161,050
+28% +$4.62M
SHLS icon
60
Shoals Technologies Group
SHLS
$1.44B
$20.4M 0.41%
828,898
-130,882
-14% -$3.16M
CFG icon
61
Citizens Financial Group
CFG
$30.6B
$20.4M 0.41%
518,408
+2,475
+0.5% +$96.6K
INTC icon
62
Intel
INTC
$492B
$20.2M 0.41%
765,403
-11,942
-2% -$332K
AMZN icon
63
Amazon
AMZN
$3T
$20.2M 0.41%
240,427
+19,713
+9% +$1.95M
VRSK icon
64
Verisk Analytics
VRSK
$23.6B
$20M 0.4%
113,295
-5,738
-5% -$1.01M
ESTA icon
65
Establishment Labs
ESTA
$2.24B
$19.9M 0.4%
303,330
FOUR icon
66
Shift4
FOUR
$3.41B
$19.9M 0.4%
355,628
+118,476
+50% +$5.6M
RIO icon
67
Rio Tinto
RIO
$166B
$19.7M 0.4%
276,920
-1,425
-0.5% -$89.5K
GPN icon
68
Global Payments
GPN
$22.8B
$19.4M 0.39%
195,579
T icon
69
AT&T
T
$165B
$19.2M 0.39%
1,043,798
+98,015
+10% +$1.75M
BMY icon
70
Bristol-Myers Squibb
BMY
$132B
$19M 0.39%
264,734
-2,260
-0.8% -$170K
GPC icon
71
Genuine Parts
GPC
$18.5B
$18.6M 0.38%
107,157
GSK icon
72
GSK
GSK
$104B
$18.5M 0.37%
525,716
-13,779
-3% -$459K
CINF icon
73
Cincinnati Financial
CINF
$26.7B
$18.3M 0.37%
178,964
-1,335
-0.7% -$138K
PRVA icon
74
Privia Health
PRVA
$2.86B
$18.2M 0.37%
800,885
+192,120
+32% +$5.35M
NVEE
75
DELISTED
NV5 Global
NVEE
$17.6M 0.36%
533,020
-85,220
-14% -$2.96M

Similar funds

Kornitzer Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Kornitzer Capital Management held 527 positions worth $4.94B, up 5.9% from $4.66B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Kornitzer Capital Management's Q4 2022 filing shows 22 new, 110 increased, 192 reduced and 28 closed positions. Its largest new stake was FIVE9: 158,520 shares worth $10.8M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Energy.

  • Kornitzer Capital Management's largest Q4 2022 buy was FIVE9: 158,520 shares worth $10.8M.
  • Kornitzer Capital Management added most to Bio-Rad Laboratories Class A in Q4 2022, an estimated $6.56M increase.
  • Kornitzer Capital Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $18.9M.
  • Kornitzer Capital Management fully exited First Advantage in Q4 2022, selling an estimated $6.24M.
  • Kornitzer Capital Management's ten largest holdings make up 17% of its $4.94B portfolio in Q4 2022.
  • Kornitzer Capital Management opened 22 new positions and closed 28 in Q4 2022.
  • Kornitzer Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.94B.

Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.